...
首页> 外文期刊>Medical hypotheses >P53-binding protein 1: a new player for tumorigenesis and a new target for breast cancer treatment.
【24h】

P53-binding protein 1: a new player for tumorigenesis and a new target for breast cancer treatment.

机译:P53结合蛋白1:肿瘤发生的新参与者和乳腺癌治疗的新靶标。

获取原文
获取原文并翻译 | 示例
           

摘要

Breast cancer remains the most common and fatal cancer in women and has been recognized as a genetic disease. Recently, accumulating evidences have showed that p53-binding protein 1 (53BP1) plays an important role in DNA double-strand breaks (DSBs) repair induced by radiation. In vitro experiments have indicated its interaction with many other genes or proteins for tumor suppression or tumorigenesis via pathways associated with DNA repair, cell-cycle control, apoptosis and cell senescence. In vivo studies also showed suppressive effect of 53BP1 on tumor initiation and progression. Therefore, we hypothesize that 53BP1 has a profound effect on suppressing breast cancer as a tumor suppressor and will be an important new biomarker for breast cancer prognosis. Furthermore, 53BP1 gene therapy will be a potential therapeutic strategy for breast cancer.
机译:乳腺癌仍然是女性中最常见和致命的癌症,已被认为是一种遗传疾病。最近,越来越多的证据表明,p53结合蛋白1(53BP1)在辐射诱导的DNA双链断裂(DSB)修复中起着重要作用。体外实验表明它与许多其他基因或蛋白质的相互作用,通过与DNA修复,细胞周期控制,细胞凋亡和细胞衰老相关的途径抑制或形成肿瘤。体内研究还显示了53BP1对肿瘤发生和发展的抑制作用。因此,我们假设53BP1作为一种抑癌剂对抑制乳腺癌具有深远的影响,并将成为乳腺癌预后的重要新生物标志物。此外,53BP1基因疗法将是乳腺癌的潜在治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号